http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2216268-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-822
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-2404
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
filingDate 1974-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2216268-A1
titleOfInvention Catalytic hydrogenation of 6-methylenetetracyclines - using rhodium-tert phosphine complex catalyst giving a stereospecific prod. in high yield
abstract 6-Methylenetetracyclines are hydrogenated by treating a tetracycline with an exocyclic methylene group with H2 in the presence of a catalyst consisting of a complex of rhodium with a tertiary phosphine of formula PR1R2R3, (where R1 and R2 are phenyl opt. substd. by e.g. alkyl, alkoxy, halogen or dialkylamino gps; and R3 and R gamma are alkyl or benzyl gp), in a solvent which dissolves both the tetracycline and the catalyst. The process produces little or no undesired anhydrotetracyclines, the reduction is practically quantitative and the catalyst is stereoselective to the production of the 6 alpha-epimer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4597904-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4973719-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE32535-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0086046-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4987242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2530490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4500458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5049683-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4997959-A
priorityDate 1973-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457773519

Total number of triples: 36.